FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christin Carter-Su

Research Profile

Chemicals & Drugs

Phenomena

Phosphorylation

Living Beings

Mouse
Rats

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Hsiao-Wen Su; Lawrence S Argetsinger; Nathan J Lanning; Carey N Lumeng; David L Morris; Christin Carter-Su
Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility.
Erin E O'Leary; Lawrence S Argetsinger; Hung T Huynh; Travis J Maures; Anna M Mazurkiewicz-Muñoz; Christin Carter-Su
Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.
Michael E Doche; Lawrence S Argetsinger; Inês Barroso; Elena G Bochukova; Christin Carter-Su; Tim Cheetham; Joel M Cline; Anne Dale; Elana Henning; Julia M Keogh; Stephen O'Rahilly; Laura R Pearce; Liangyou Rui; Hsiao-Wen Su; Sadia Saeed; I Sadaf Farooqi
Human SH2B1 mutations are associated with maladaptive behaviors and obesity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christin Carter-Su (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hsiao-Wen Su; Lawrence S Argetsinger; Nathan J Lanning; Carey N Lumeng; David L Morris; Christin Carter-Su
Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility.
Journal of cell science 2013;126(Pt 8):1733-43.
2013: Erin E O'Leary; Lawrence S Argetsinger; Hung T Huynh; Travis J Maures; Anna M Mazurkiewicz-Muñoz; Christin Carter-Su
Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.
Molecular endocrinology (Baltimore, Md.) 2013;27(4):619-34.
2012: Michael E Doche; Lawrence S Argetsinger; Inês Barroso; Elena G Bochukova; Christin Carter-Su; Tim Cheetham; Joel M Cline; Anne Dale; Elana Henning; Julia M Keogh; Stephen O'Rahilly; Laura R Pearce; Liangyou Rui; Hsiao-Wen Su; Sadia Saeed; I Sadaf Farooqi
Human SH2B1 mutations are associated with maladaptive behaviors and obesity.
The Journal of clinical investigation 2012;122(12):4732-6.
2012: Vincent Goffin; Christin Carter-Su
Meeting report: the 2012 FASEB Science Research Conference "The growth hormone/prolactin family in biology and disease" A novel biannual rendez-vous in the endocrinology landscape.
Pediatric endocrinology reviews : PER 2012;10(2):243-5.
2012: Mojib Javadi; Natalie Stickle; Bryan K Beattie; Christin Carter-Su; Edda Hofstätter; Robert Jaster; Dwayne L Barber
The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.
The Journal of biological chemistry 2012;287(31):26223-34.
2012: Bridgette N Ray; Philip C Andrews; Lawrence S Argetsinger; Diane C Fingar; Hye Kyong Kweon; Christin Carter-Su
Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics.
Molecular endocrinology (Baltimore, Md.) 2012;26(6):1056-73.
2012: Haoran Su; Christin Carter-Su; Lin Jiang; Liangyou Rui
Glucose enhances leptin signaling through modulation of AMPK activity.
PloS one 2012;7(2):e31636.
2011: Nathan J Lanning; Hsiao-Wen Su; Lawrence S Argetsinger; Christin Carter-Su
Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number.
Journal of cell science 2011;124(Pt 18):3095-105.
2011: Christin Carter-Su; Lawrence S Argetsinger
JAKs, Stats, and CK2?
Blood 2011;118(1):5-6.
2011: Travis J Maures; Hsiao-Wen Su; Lawrence S Argetsinger; Sergio Grinstein; Christin Carter-Su
Phosphorylation controls a dual-function polybasic nuclear localization sequence in the adapter protein SH2B1β to regulate its cellular function and distribution.
Journal of cell science 2011;124(Pt 9):1542-52.
2011: Tracy Xiao Cui; Grace Lin; Christopher R LaPensee; Anda-Alexandra Calinescu; Maanjot Rathore; Cale Streeter; Graciela Piwien-Pilipuk; Nathan Lanning; Hui Jin; Christin Carter-Su; Zhaohui S Qin; Jessica Schwartz
C/EBPβ mediates growth hormone-regulated expression of multiple target genes.
Molecular endocrinology (Baltimore, Md.) 2011;25(4):681-93.
2010: Lawrence S Argetsinger; Jeanne A Stuckey; Scott A Robertson; Rositsa I Koleva; Joel M Cline; Jarrod A Marto; Martin G Myers Jr; Christin Carter-Su
Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity.
Molecular endocrinology (Baltimore, Md.) 2010;24(5):1062-76.
2009: Travis J Maures; Linyi Chen; Christin Carter-Su
Nucleocytoplasmic shuttling of the adapter protein SH2B1beta (SH2-Bbeta) is required for nerve growth factor (NGF)-dependent neurite outgrowth and enhancement of expression of a subset of NGF-responsive genes.
Molecular endocrinology (Baltimore, Md.) 2009;23(7):1077-91.
2009: Scott A Robertson; Rositsa I Koleva; Lawrence S Argetsinger; Christin Carter-Su; Jarrod A Marto; Edward P Feener; Martin G Myers Jr
Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling.
Molecular and cellular biology 2009;29(12):3367-78.
2009: Brian R Thompson; Anna M Mazurkiewicz-Muñoz; Jill Suttles; Christin Carter-Su; David A Bernlohr
Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling.
The Journal of biological chemistry 2009;284(20):13473-80.
2009: Celine C Berthier; Hongyu Zhang; MaryLee Schin; Anna Henger; Robert G Nelson; Berne Yee; Anissa Boucherot; Matthias A Neusser; Clemens D Cohen; Christin Carter-Su; Lawrence S Argetsinger; Maria Pia Rastaldi; Frank C Brosius III; Matthias Kretzler
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
Diabetes 2009;58(2):469-77.
2008: Hui Jin; Nathan J Lanning; Christin Carter-Su
JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.
Molecular endocrinology (Baltimore, Md.) 2008;22(8):1825-41.
2008: Linyi Chen; Travis J Maures; Hui Jin; Jeffrey S Huo; Shafaat A Rabbani; Jessica Schwartz; Christin Carter-Su
SH2B1beta (SH2-Bbeta) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10.
Molecular endocrinology (Baltimore, Md.) 2008;22(2):454-76.
2007: Zhiqin Li; Yingjiang Zhou; Christin Carter-Su; Martin G Myers Jr; Liangyou Rui
SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms.
Molecular endocrinology (Baltimore, Md.) 2007;21(9):2270-81.
2007: Maria Diakonova; Emmanuèle Helfer; Stéphanie Seveau; Joel A Swanson; Christine Kocks; Liangyou Rui; Marie-France Carlier; Christin Carter-Su
Adapter protein SH2-Bbeta stimulates actin-based motility of Listeria monocytogenes in a vasodilator-stimulated phosphoprotein (VASP)-dependent fashion.
Infection and immunity 2007;75(7):3581-93.
2007: Peilin Yang; Rebecca J Whelan; Yingwei Mao; Angel W Lee; Christin Carter-Su; Robert T Kennedy
Multiplexed detection of protein-peptide interaction and inhibition using capillary electrophoresis.
Analytical chemistry 2007;79(4):1690-5.
2007: Travis J Maures; Jason H Kurzer; Christin Carter-Su
SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other.
Trends in endocrinology and metabolism: TEM 2007;18(1):38-45.
2006: Nathan J Lanning; Christin Carter-Su
Recent advances in growth hormone signaling.
Reviews in endocrine & metabolic disorders 2006;7(4):225-35.
2006: Jason H Kurzer; Pipsa Saharinen; Olli Silvennoinen; Christin Carter-Su
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.
Molecular and cellular biology 2006;26(17):6381-94.
2006: Anna M Mazurkiewicz-Munoz; Lawrence S Argetsinger; Jean-Louis K Kouadio; Allan Stensballe; Ole N Jensen; Joel M Cline; Christin Carter-Su
Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.
Molecular and cellular biology 2006;26(11):4052-62.
2005: Christin Carter-Su
Mentoring for success in physiology. Bodil M. Schmidt Nielsen Award presentation.
The Physiologist 2005;48(4):167, 172-8.
2005: Peilin Yang; Rebecca J Whelan; Emily E Jameson; Jason H Kurzer; Lawrence S Argetsinger; Christin Carter-Su; Abuzar Kabir; Abdul Malik; Robert T Kennedy
Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-Bbeta as a model system.
Analytical chemistry 2005;77(8):2482-9.
2004: Lawrence S Argetsinger; Jean-Louis K Kouadio; Hanno Steen; Allan Stensballe; Ole N Jensen; Christin Carter-Su
Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.
Molecular and cellular biology 2004;24(11):4955-67.
2004: Jason H Kurzer; Lawrence S Argetsinger; Yong-Jie Zhou; Jean-Louis K Kouadio; John O'Shea; Christin Carter-Su
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.
Molecular and cellular biology 2004;24(10):4557-70.
2004: Linyi Chen; Christin Carter-Su
Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation.
Molecular and cellular biology 2004;24(9):3633-47.
2004: Huibin Tang; Peter C D Macpherson; Lawrence S Argetsinger; Danuta Cieslak; Steven T Suhr; Christin Carter-Su; Daniel Goldman
CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes.
Cellular signalling 2004;16(5):551-63.
2004: Xiaohong Wang; Linyi Chen; Travis J Maures; James Herrington; Christin Carter-Su
SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells.
The Journal of biological chemistry 2004;279(1):133-41.
2003: Karen B O'Brien; Lawrence S Argetsinger; Maria Diakonova; Christin Carter-Su
YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.
The Journal of biological chemistry 2003;278(14):11970-8.
2002: Maria Diakonova; David R Gunter; James Herrington; Christin Carter-Su
SH2-Bbeta is a Rac-binding protein that regulates cell motility.
The Journal of biological chemistry 2002;277(12):10669-77.
2002: Karen B O'Brien; John O'Shea; Christin Carter-Su
SH2-B family members differentially regulate JAK family tyrosine kinases.
The Journal of biological chemistry 2002;277(10):8673-81.
2001: James Herrington; Christin Carter-Su
Signaling pathways activated by the growth hormone receptor.
Trends in endocrinology and metabolism: TEM 2001;12(6):252-7.
2000: MR Stofega; Lawrence S Argetsinger; Haiyang Wang; A Ullrich; Christin Carter-Su
Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
The Journal of biological chemistry 2000;275(36):28222-9.
2000: MR Stofega; James Herrington; Nils Billestrup; Christin Carter-Su
Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
Molecular endocrinology (Baltimore, Md.) 2000;14(9):1338-50.
2000: Y Zhang; James Turkson; Christin Carter-Su; Thomas E Smithgall; Alexander Levitzki; Alan J Kraker; J J Krolewski; P Medveczky; Richard Jove
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
The Journal of biological chemistry 2000;275(32):24935-44.
2000: Christin Carter-Su; Liangyou Rui; James Herrington
Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.
Pediatric nephrology (Berlin, Germany) 2000;14(7):550-7.
2000: James Herrington; LS Smit; Jessica Schwartz; Christin Carter-Su
The role of STAT proteins in growth hormone signaling.
Oncogene 2000;19(21):2585-97.
2000: Liangyou Rui; David R Gunter; James Herrington; Christin Carter-Su
Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Molecular and cellular biology 2000;20(9):3168-77.
2000: James Herrington; Maria Diakonova; Liangyou Rui; David R Gunter; Christin Carter-Su
SH2-B is required for growth hormone-induced actin reorganization.
The Journal of biological chemistry 2000;275(17):13126-33.
2000: Liangyou Rui; S F Archer; Lawrence S Argetsinger; Christin Carter-Su
Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway.
The Journal of biological chemistry 2000;275(4):2885-92.
2000: Christin Carter-Su; Liangyou Rui; MR Stofega
SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
Recent progress in hormone research 2000;55():293-311.
1999: Liangyou Rui; James Herrington; Christin Carter-Su
SH2-B, a membrane-associated adapter, is phosphorylated on multiple serines/threonines in response to nerve growth factor by kinases within the MEK/ERK cascade.
The Journal of biological chemistry 1999;274(37):26485-92.
1999: Liangyou Rui; Christin Carter-Su
Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(13):7172-7.
1999: Liangyou Rui; James Herrington; Christin Carter-Su
SH2-B is required for nerve growth factor-induced neuronal differentiation.
The Journal of biological chemistry 1999;274(15):10590-4.
1999: James Herrington; Liangyou Rui; G Luo; L Y Yu-Lee; Christin Carter-Su
A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B.
The Journal of biological chemistry 1999;274(8):5138-45.
1998: Mario D Galigniana; J L Scruggs; James Herrington; Michael J Welsh; Christin Carter-Su; Paul R Housley; William B Pratt
Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.
Molecular endocrinology (Baltimore, Md.) 1998;12(12):1903-13.
1998: C Hodge; J Liao; MR Stofega; Kunliang Guan; Christin Carter-Su; Jessica Schwartz
Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2.
The Journal of biological chemistry 1998;273(47):31327-36.
1998: Liangyou Rui; Christin Carter-Su
Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta.
The Journal of biological chemistry 1998;273(33):21239-45.
1998: Tzy-Wen L Gong; D J Meyer; J Liao; Christina L Hodge; GS Campbell; X Wang; Nils Billestrup; Christin Carter-Su; Jessica Schwartz
Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
Endocrinology 1998;139(4):1863-71.
1998: MR Stofega; Haiyang Wang; A Ullrich; Christin Carter-Su
Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association.
The Journal of biological chemistry 1998;273(12):7112-7.
1998: Christin Carter-Su; LS Smit
Signaling via JAK tyrosine kinases: growth hormone receptor as a model system.
Recent progress in hormone research 1998;53():61-82; discussion 82-3.
1997: Liangyou Rui; Lawrence S Mathews; K Hotta; TA Gustafson; Christin Carter-Su
Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
Molecular and cellular biology 1997;17(11):6633-44.
1997: J A Vanderkuur; Elizabeth R Butch; S B Waters; Jeffrey Pessin; Kun-Liang Guan; Christin Carter-Su
Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
Endocrinology 1997;138(10):4301-7.
1997: LS Smit; J A Vanderkuur; A Stimage; Y Han; G Luo; L Y Yu-Lee; Jessica Schwartz; Christin Carter-Su
Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Endocrinology 1997;138(8):3426-34.
1997: GS Campbell; CL Yu; Richard Jove; Christin Carter-Su
Constitutive activation of JAK1 in Src-transformed cells.
The Journal of biological chemistry 1997;272(5):2591-4.
1996: Lawrence S Argetsinger; Gunnar Norstedt; Nils Billestrup; M F White; Christin Carter-Su
Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling.
The Journal of biological chemistry 1996;271(46):29415-21.
1996: Andrzej Dabrowski; J A VanderKuur; Christin Carter-Su; John Williams
Cholecystokinin stimulates formation of shc-grb2 complex in rat pancreatic acinar cells through a protein kinase C-dependent mechanism.
The Journal of biological chemistry 1996;271(43):27125-9.
1996: Christin Carter-Su; Anthony King; Lawrence S Argetsinger; L S Smit; J Vanderkuur; G S Campbell
Signalling pathway of GH.
Endocrine journal 1996;43 Suppl():S65-70.
1996: Lawrence S Argetsinger; Christin Carter-Su
Mechanism of signaling by growth hormone receptor.
Physiological reviews 1996;76(4):1089-107.
1996: Anthony King; M J Tseng; Craig D Logsdon; Nils Billestrup; Christin Carter-Su
Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization.
The Journal of biological chemistry 1996;271(30):18088-94.
1996: L S Smit; D J Meyer; Nils Billestrup; Gunnar Norstedt; Jessica Schwartz; Christin Carter-Su
The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Molecular endocrinology (Baltimore, Md.) 1996;10(5):519-33.
1996: LF Stancato; M David; Christin Carter-Su; Andrew C Larner; William B Pratt
Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.
The Journal of biological chemistry 1996;271(8):4134-7.
1996: Christin Carter-Su; Jessica Schwartz; L S Smit
Molecular mechanism of growth hormone action.
Annual review of physiology 1996;58():187-207.
1996: Lawrence S Argetsinger; Christin Carter-Su
Growth hormone signalling mechanisms: involvement of the tyrosine kinase JAK2.
Hormone research 1996;45 Suppl 1():22-4.
1995: Anthony King; Christin Carter-Su
Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
Endocrinology 1995;136(11):4796-803.
1995: J A VanderKuur; X Wang; Lizhi Zhang; G Allevato; Nils Billestrup; Christin Carter-Su
Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
The Journal of biological chemistry 1995;270(37):21738-44.
1995: C L Yu; D J Meyer; G S Campbell; Andrew C Larner; Christin Carter-Su; Jessica Schwartz; Richard Jove
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
Science (New York, N.Y.) 1995;269(5220):81-3.
1995: Lawrence S Argetsinger; G W Hsu; Martin G Myers Jr; Nils Billestrup; M F White; Christin Carter-Su
Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
The Journal of biological chemistry 1995;270(24):14685-92.
1995: J VanderKuur; G Allevato; Nils Billestrup; Gunnar Norstedt; Christin Carter-Su
Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
The Journal of biological chemistry 1995;270(13):7587-93.
1995: G S Campbell; D J Meyer; R Raz; D E Levy; Jessica Schwartz; Christin Carter-Su
Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone.
The Journal of biological chemistry 1995;270(8):3974-9.
1994: J A VanderKuur; X Wang; Lizhi Zhang; G S Campbell; G Allevato; Nils Billestrup; Gunnar Norstedt; Christin Carter-Su
Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
The Journal of biological chemistry 1994;269(34):21709-17.
1994: Christin Carter-Su; Lawrence S Argetsinger; G S Campbell; X Wang; James N Ihle; bruce witthuhn
The identification of JAK2 tyrosine kinase as a signaling molecule for growth hormone.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1994;206(3):210-5.
1994: G S Campbell; Lawrence S Argetsinger; James N Ihle; P A Kelly; James A Rillema; Christin Carter-Su
Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5232-6.
1994: D J Meyer; G S Campbell; Brent H Cochran; Lawrence S Argetsinger; Andrew C Larner; D S Finbloom; Christin Carter-Su; Jessica Schwartz
Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor.
The Journal of biological chemistry 1994;269(7):4701-4.
1993: Lawrence S Argetsinger; G S Campbell; X Yang; bruce witthuhn; O Silvennoinen; James N Ihle; Christin Carter-Su
Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
Cell 1993;74(2):237-44.
1993: G S Campbell; L J Christian; Christin Carter-Su
Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone.
The Journal of biological chemistry 1993;268(10):7427-34.
1993: X Wang; C Möller; Gunnar Norstedt; Christin Carter-Su
Growth hormone-promoted tyrosyl phosphorylation of a 121-kDa growth hormone receptor-associated protein.
The Journal of biological chemistry 1993;268(5):3573-9.
1992: P K Tai; J F Liao; PA Hossler; C William Castor; Christin Carter-Su
Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
The Journal of biological chemistry 1992;267(27):19579-86.
1992: X Wang; Michael D Uhler; Nils Billestrup; Gunnar Norstedt; F Talamantes; Jens H Nielsen; Christin Carter-Su
Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase.
The Journal of biological chemistry 1992;267(24):17390-6.
1992: James A Rillema; G S Campbell; David Lawson; Christin Carter-Su
Evidence for a rapid stimulation of tyrosine kinase activity by prolactin in Nb2 rat lymphoma cells.
Endocrinology 1992;131(2):973-5.
1992: G S Campbell; L Pang; T Miyasaka; Alan Saltiel; Christin Carter-Su
Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts.
The Journal of biological chemistry 1992;267(9):6074-80.
1992: S E Stred; J R Stubbart; Lawrence S Argetsinger; W C Smith; J A Shafer; F Talamantes; Christin Carter-Su
Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.
Endocrinology 1992;130(3):1626-36.
1991: Anthony King; P K Tai; Christin Carter-Su
Cytochalasin B interferes with conformational changes of the human erythrocyte glucose transporter induced by internal and external sugar binding.
Biochemistry 1991;30(49):11546-53.
1991: J R Stubbart; David F Barton; P K Tai; S E Stred; E Gorin; H M Goodman; Christin Carter-Su
Antibodies to cytoplasmic sequences of cloned liver growth hormone (GH) receptors recognize GH receptors associated with tyrosine kinase activity.
Endocrinology 1991;129(3):1659-70.
1991: M K Sinha; C Raineri-Maldonado; C Buchanan; Walter J Pories; Christin Carter-Su; P F Pilch; JF Caro
Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform.
Diabetes 1991;40(4):472-7.
1990: P K Tai; J F Liao; E H Chen; J Dietz; Jessica Schwartz; Christin Carter-Su
Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells.
The Journal of biological chemistry 1990;265(35):21828-34.
1990: James M May; Adina Buchs; Christin Carter-Su
Localization of a reactive exofacial sulfhydryl on the glucose carrier of human erythrocytes.
Biochemistry 1990;29(45):10393-8.
1990: S E Stred; J R Stubbart; Lawrence S Argetsinger; J A Shafer; Christin Carter-Su
Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types.
Endocrinology 1990;127(5):2506-16.
1989: Christin Carter-Su; J R Stubbart; X Y Wang; S E Stred; Lawrence S Argetsinger; J A Shafer
Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase.
The Journal of biological chemistry 1989;264(31):18654-61.
1988: Christin Carter-Su; Frank W Rozsa; X Wang; J R Stubbart
Rapid and transitory stimulation of 3-O-methylglucose transport by growth hormone.
The American journal of physiology 1988;255(5 Pt 1):E723-9.
1988: P K Tai; Christin Carter-Su
Monoclonal antibody to the human glucose transporter that differentiates between the glucose and nucleoside transporters.
Biochemistry 1988;27(16):6062-71.
1988: Jessica Schwartz; Christin Carter-Su
Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells: dependence on cell differentiation.
Endocrinology 1988;122(5):2247-56.
1988: Carol M Foster; J A Shafer; Frank W Rozsa; X Y Wang; S D Lewis; D A Renken; JoAnne Natale; Jessica Schwartz; Christin Carter-Su
Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes.
Biochemistry 1988;27(1):326-34.
1987: Jessica Schwartz; Christin Carter-Su
Growth hormone receptor structure in adipocytes from normal and growth hormone-deficient rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1987;19(6):242-8.
1987: Christin Carter-Su; K Okamoto
Effect of insulin and glucocorticoids on glucose transporters in rat adipocytes.
The American journal of physiology 1987;252(4 Pt 1):E441-53.
1985: Christin Carter-Su; K Okamoto
Effect of glucocorticoids on hexose transport in rat adipocytes. Evidence for decreased transporters in the plasma membrane.
The Journal of biological chemistry 1985;260(20):11091-8.
1985: C William Castor; A M Furlong; Christin Carter-Su
Connective tissue activation: stimulation of glucose transport by connective tissue activating peptide III.
Biochemistry 1985;24(7):1762-7.
1985: Christin Carter-Su; K Okamoto
Inhibition of hexose transport in adipocytes by dexamethasone: role of protein synthesis.
The American journal of physiology 1985;248(2 Pt 1):E215-23.
1984: Christin Carter-Su; Jessica Schwartz; G Kikuchi
Identification of a high affinity growth hormone receptor in rat adipocyte membranes.
The Journal of biological chemistry 1984;259(2):1099-104.
1982: Christin Carter-Su; Jeffrey Pessin; R Mora; W Gitomer; M P Czech
Photoaffinity labeling of the human erythrocyte D-glucose transporter.
The Journal of biological chemistry 1982;257(10):5419-25.
1982: Jeffrey Pessin; L G Tillotson; K Yamada; W Gitomer; Christin Carter-Su; R Mora; K J Isselbacher; M P Czech
Identification of the stereospecific hexose transporter from starved and fed chicken embryo fibroblasts.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(7):2286-90.
1981: Christin Carter-Su; P F Pilch; M P Czech
Chromatographic resolution of insulin receptor from insulin-sensitive D-glucose transporter of adipocyte plasma membranes.
Biochemistry 1981;20(1):216-21.
1980: Christin Carter-Su; M P Czech
Reconstitution of D-glucose transport activity from cytoplasmic membranes. Evidence against recruitment of cytoplasmic membrane transporters into the plasma membrane as the sole action of insulin.
The Journal of biological chemistry 1980;255(21):10382-6.
1980: D J Pillion; Christin Carter-Su; P F Pilch; M P Czech
Isolation of adipocyte plasma membrane antigens by immunoaffinity chromatography. Insulinomimetic antibodies do not bind directly to the insulin receptor or the glucose transport system.
The Journal of biological chemistry 1980;255(19):9168-76.
1980: Christin Carter-Su; D J Pillion; M P Czech
Reconstituted D-glucose transport from the adipocyte plasma membrane. Chromatographic resolution of transport activity from membrane glycoproteins using immobilized concanavalin A.
Biochemistry 1980;19(11):2374-85.
1980: Christin Carter-Su; G A Kimmich
Effect of membrane potential on Na+-dependent sugar transport by ATP-depleted intestinal cells.
The American journal of physiology 1980;238(3):C73-80.
1980: Christin Carter-Su; M P Czech
Retention of insulin-stimulated D-glucose transport by detergent-solubilized adipocyte plasma membrane proteins reconstituted into phospholipid vesicles.
Annals of the New York Academy of Sciences 1980;358():332-3.
1980: M P Czech; J Massague; P F Pilch; Christin Carter-Su
Structural features of the insulin effector system: relation to hexose transport activation.
Annals of the New York Academy of Sciences 1980;358():282-91.
1979: Christin Carter-Su; G A Kimmich
Membrane potentials and sugar transport by ATP-depleted intestinal cells: effect of anion gradients.
The American journal of physiology 1979;237(1):C67-74.
1978: G A Kimmich; Christin Carter-Su
Membrane potentials and the energetics of intestinal Na+-dependent transport systems.
The American journal of physiology 1978;235(3):C73-81.
1977: G A Kimmich; Christin Carter-Su; J Randles
Energetics of Na+-dependent sugar transport by isolated intestinal cells: evidence for a major role for membrane potentials.
The American journal of physiology 1977;233(5):E357-62.